TD Cowen Cuts P3 Health Partners (NASDAQ:PIII) Price Target to $3.00

P3 Health Partners (NASDAQ:PIII) had its target price trimmed by TD Cowen from $8.00 to $3.00 in a research note released on Thursday,Benzinga reports. The firm currently has a hold rating on the stock.

Several other research firms have also recently weighed in on PIII. Lake Street Capital dropped their price objective on shares of P3 Health Partners from $12.50 to $4.00 and set a “buy” rating for the company in a research report on Friday, March 27th. BTIG Research reissued a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of P3 Health Partners in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $3.50.

P3 Health Partners Price Performance

Shares of NASDAQ:PIII opened at $2.57 on Thursday. P3 Health Partners has a 52-week low of $1.52 and a 52-week high of $11.30. The company has a 50 day moving average of $2.46 and a two-hundred day moving average of $4.96. The company has a market capitalization of $18.53 million, a price-to-earnings ratio of -0.06 and a beta of 0.57.

P3 Health Partners (NASDAQ:PIII) last announced its earnings results on Thursday, March 26th. The company reported ($23.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($8.06) by ($14.96). P3 Health Partners had a negative return on equity of 302.33% and a negative net margin of 10.14%.The company had revenue of $384.81 million during the quarter, compared to the consensus estimate of $357.65 million. On average, equities analysts anticipate that P3 Health Partners will post -0.67 earnings per share for the current year.

Hedge Funds Weigh In On P3 Health Partners

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC boosted its holdings in shares of P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 26,678 shares of the company’s stock after acquiring an additional 1,178 shares during the period. Trinity Financial Advisors LLC owned 0.37% of P3 Health Partners worth $239,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.